Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halliwell

Showing results (991-1000 of 1,037) with videos related to

Pageof 104
Sort By:
Scientific Reports|April 17, 2026
Ergothioneine as a potential protective agent against macular degeneration and other eye disordersIrwin K Cheah, Zachary WeiJie Fong, Lucrecia Chen, et al.
Free Radical Biology & Medicine|December 9, 2009
Oxidative damage in Parkinson disease: Measurement using accurate biomarkersRaymond C S Seet, Chung-Yung J Lee, Erle C H Lim, et al.
Health and Social Care Delivery Research|October 18, 2024
Health and wellbeing of survivors of sexual violence and abuse attending sexual assault referral centres in England: the MESARCH mixed-methods evaluationLorna J O'Doherty, Grace Carter, Emma Sleath, et al.
BMC Public Health|May 26, 2021
ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trialGail Gilchrist, Laura Potts, Polly Radcliffe, et al.
Acta Neuropathologica|March 23, 2011
The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS geneJulie S Snowden, Quan Hu, Sara Rollinson, et al.
Acta Neuropathologica|May 18, 2001
Characterisation of molecular alterations in microdissected archival gliomasC Walker, K A Joyce, J Thompson-Hehir, et al.
Cytotherapy|November 17, 2022
Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cellsEmma Halliwell, Alice Vitali, Henrike Muller, et al.
Pilot and Feasibility Studies|May 20, 2020
A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatmentGail Gilchrist, Sabine Landau, Polly Radcliffe, et al.
Stroke|June 25, 2011
Oxidative damage in ischemic stroke revealed using multiple biomarkersRaymond C S Seet, Chung-Yung J Lee, Bernard P L Chan, et al.
Journal of Neurochemistry|July 5, 2005
Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysisElaine Hau Jin Yew, Nam Sang Cheung, Meng Shyan Choy, et al.
Pageof 104

Showing results (991-1000 of 1,037) with videos related to

Sort By:
Pageof 104
Scientific Reports|April 17, 2026
Ergothioneine as a potential protective agent against macular degeneration and other eye disordersIrwin K Cheah, Zachary WeiJie Fong, Lucrecia Chen, et al.
Free Radical Biology & Medicine|December 9, 2009
Oxidative damage in Parkinson disease: Measurement using accurate biomarkersRaymond C S Seet, Chung-Yung J Lee, Erle C H Lim, et al.
Health and Social Care Delivery Research|October 18, 2024
Health and wellbeing of survivors of sexual violence and abuse attending sexual assault referral centres in England: the MESARCH mixed-methods evaluationLorna J O'Doherty, Grace Carter, Emma Sleath, et al.
BMC Public Health|May 26, 2021
ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trialGail Gilchrist, Laura Potts, Polly Radcliffe, et al.
Acta Neuropathologica|March 23, 2011
The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS geneJulie S Snowden, Quan Hu, Sara Rollinson, et al.
Acta Neuropathologica|May 18, 2001
Characterisation of molecular alterations in microdissected archival gliomasC Walker, K A Joyce, J Thompson-Hehir, et al.
Cytotherapy|November 17, 2022
Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cellsEmma Halliwell, Alice Vitali, Henrike Muller, et al.
Pilot and Feasibility Studies|May 20, 2020
A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatmentGail Gilchrist, Sabine Landau, Polly Radcliffe, et al.
Stroke|June 25, 2011
Oxidative damage in ischemic stroke revealed using multiple biomarkersRaymond C S Seet, Chung-Yung J Lee, Bernard P L Chan, et al.
Journal of Neurochemistry|July 5, 2005
Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysisElaine Hau Jin Yew, Nam Sang Cheung, Meng Shyan Choy, et al.
Pageof 104